A Clinical trial to evaluate the efficacy of Transcranial Direct Current Stimulations (TDCS) on movement and cognitive functions in patients with subacute brain ischemic stroke

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017070921965N7

Enrollment

100

Registered

2017-08-04

Start date

2017-07-09

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke. Vascular syndromes of brain in cerebrovascular diseases

Interventions

Intervention 1: Intervention group1: The treatment will be carried out in 15 sessions, three sessions per week and a consistent, direct and uniform current will be sent to the brain through anodal typ

Treatment - Other

Intervention group1: The treatment will be carried out in 15 sessions, three sessions per week and a consistent, direct and uniform current will be sent to the brain through anodal type waves for up t

Intervention group2: The treatment will be carried out in 15 sessions, three sessions per week and a consistent, direct and uniform current will be sent to the brain through cathodal type waves for up

Sham Group: Sham group will get electrical stimulation (TDCS) in the initial moments of each treatment session then the current will be switched off.

Control group: Control group will not have an electrical stimulation (TDCS) of the brain.

Eligibility

Sex/Gender

All

Age

21 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with the brain stroke; people aged at least 21 years during 48 hours of their first brain stroke; Exclusion criteria: cardiac pacemaker or metal implants or instruments inside the patient’s body; treatment resistant seizures; using any psychoactive or stimulation drugs; pregnancy; the existence of any neurological condition affecting sensory-motor systems; such as brain tumors; dementia; or severe substance abuse and medications.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Movement and cognitive functions. Timepoint: Treatment effectiveness will be assessed after 15 days, 1 month and 3 month later by using of National Institutes of Health Stroke Scale. Method of measurement: National Institutes of Health Stroke Scale, REY Verbal Memory Test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Kiomars Najafi

Guilan University Of Medical Sciences

kkiomars@yahoo.com+98 13 3366 6268

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026